Epilepsy: Five new things
- Leslie A. Rudzinski,
- Kimford J. Meador
- Emory University
Scholary Output:
Contribution to journal
Article
Peer-reviewPublication Information
Output type
Scholary Output:
Contribution to journal
Article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages S20-S24Journal (Volume, Issue Number)
Neurology (Volume 76, Issue 7 SUPPL. 2)Publication milestones
- Published - 02/15/2011
Publication status
Published - 02/15/2011
ISSN
0028-3878Publication IDs
- Scopus: 79951637462
- PubMed: 21321347
Publication metrics
Metrics
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1
SciVal
FWCI
0.80
SciVal
Author count
2
SciVal
citations
15
SciVal
Paper percentile
72
PlumX, opens in new tab
Citation count
18
Captures
59
Mentions
3
Social media
24
Funding Details
Dr. Rudzinski reports no disclosures. Dr. Meador serves on the editorial boards of Neurology ®, Behavior & Neurology, Epilepsy and Behavior, Epilepsy Currents , Epilepsy.com , and the Journal of Clinical Neurophysiology and on the Professional Advisory Board for the Epilepsy Foundation; received travel support from Sanofi-Aventis; and received research support from GlaxoSmithKline, Eisai Inc., Marinus Pharmaceuticals, Inc., Myriad Genetics, Inc., NeuroPace, Inc., Pfizer, SAM Technology Inc., Schwartz Pharma (UCB), the NIH/NINDS, and the Epilepsy Foundation.
FundersFunding numbers
Epilepsy Institutes of the Netherlands Foundation
-Epilepsy and Behavior
-NIH/NINDS
-UCB
-Eisai
-SAM Technology Inc.
-Pfizer
-Sanofi
-GSK
-